SARS – CoV – 2 Spike RBM (receptor binding motif), 500 – 509 – 0.5 mg

Overview

The SARS-CoV-2 Spike RBM (receptor binding motif) peptide, spanning residues 500 to 509, is a vital component for researchers studying the virus’s interaction with its receptor. This peptide is derived from the receptor binding domain (RBD) identified within the spike protein of SARS-CoV-2, specifically referencing the sequence from RefSeq (YP_009724390.1). Understanding this motif is crucial for developing diagnostic tools and therapeutic strategies against COVID-19.

Key Features

• Precise sequence: RBM peptide sequence 500-509.
• Essential for receptor binding studies of SARS-CoV-2.
• Supports vaccine and therapeutic development.
• Available in 0.5 mg quantity for flexibility in research.
• Produced under strict quality control for reliability.

Specifications

FAQ

What is the purpose of the SARS-CoV-2 Spike RBM peptide?

This peptide is primarily used in research to understand how the spike protein binds to the ACE2 receptor, which is essential for the virus’s entry into host cells.

How can this peptide aid in vaccine development?

By studying the receptor binding motif, researchers can identify critical interactions and design more effective vaccines that elicit targeted immune responses.

Where can I find more related products?

You can explore our full range of peptides and related products to enhance your research on SARS-CoV-2 and other biological systems, including our PKG Substrate and Autocamtide-2.

For any specific inquiries or to place an order, reach out to our support team. Enhance your research with our high-quality SARS-CoV-2 Spike RBM (500-509) peptide today!

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.